KAID Health builds the Whole Chart Analysis™ platform, an NLP-centric solution that integrates structured EMR data and insights distilled from clinical notes using the latest language models. The product collects comprehensive patient data to improve coding accuracy, capture, quality reporting, and care management while reducing clinician and staff burden. KAID's technology is used across leading providers, health systems, academic medical centers, and payers and is proven in commercial settings and peer-reviewed literature. Today it improves Medicare Advantage coding accuracy and completeness for large provider groups across the U.S. and also streamlines chart review for prior authorization, clinical trial enrollment, and preoperative risk identification. With new funding, KAID plans to bolster its market footprint among providers and payer partners and to enable significant service expansion. KAID Health’s core product is a natural language processing–centric Whole Chart Analysis platform that extracts structured and text data from electronic medical records and pushes identified care and coding gaps into provider workflows. The platform can financially reward providers for timely completion of assigned tasks and is used across use cases including Medicare Advantage coding accuracy, automated quality metric reporting, prior authorization chart review, and pre-operative risk identification. KAID sells to and works with providers, health systems, academic medical centers, payers, and Accountable Care Organizations. The company reports that its solution has delivered over 10x return on investment for customers and is built in conjunction with leading provider organizations. With the new financing, KAID plans to bolster its market footprint among providers while furthering collaboration between providers and health plans and ACO partners. The company is based in Boston, MA.

Total raised

$4M

Funding rounds

2

Latest round

Series A

Latest activity

May 2022